About this journal

Aims and scope

Please note, from 2022 the Print ISSN is not in active use as this journal is no longer published in print.

Molecular & Cellular Oncology is an international journal publishing fundamental, translational and clinical research on all aspects of oncogenesis, tumor progression and therapeutic strategies.

Topics covered include:

  • All solid and hematological cancers;
  • Mechanistic insights into molecular pathways and cellular processes;
  • Cell growth regulation, signal transduction, and apoptosis;
  • Tumor microenvironment and immunosurveillance;
  • Transcriptomics, proteomics, and metabolomics.

Molecular & Cellular Oncology publishes original research, reviews, short articles, commentaries, and author views.

*Please note that Molecular & Cellular Oncology converted to a full Open Access journal from Volume 9 (2022).

Publication office: Taylor & Francis, Inc., 530 Walnut Street, Suite 850, Philadelphia, PA 19106.

Journal metrics

Usage

  • 175K annual downloads/views

Citation metrics

  • 2.6 (2023) Impact Factor
  • 1.6 (2023) 5 year IF
  • 3.2 (2023) CiteScore (Scopus)
  • 0.231 (2023) SNIP
  • 0.471 (2023) SJR

Speed/acceptance

  • 3 days avg. from submission to first decision
  • 9% acceptance rate

Editorial board

Editors-in-Chief
Lorenzo Galluzzi - Weill Cornell Medical College, New York, NY, US
Ilio Vitale - The University of Rome Tor Vergata, Rome, IT

Founding Editors

Lorenzo Galluzzi - Weill Cornell Medical College, New York, NY, US
Guido Kroemer - University of Paris Descartes, Paris, FR

Scientific Advisory Board

Sandy Adjemian - VIB Center for Inflammation Research, Ghent, Belgium
David W. Andrews - University of Toronto, Toronto, ON, CA
Ralph DeBarardinis - Southwestern Medical Center, University of Texas, Dallas, TX, US

Niccolo Bartalucci, Center of Research and Innovation for Myeloproliferative Neoplasms (CRIMM), University of Florence, Italy
Jose Manuel Bravo-San Pedro, Universite de Paris, France
Eric Deutsch - Gustave-Roussy, France
Vishva Dixit - Genentech, Inc., South San Francisco, CA, US
Nicolas Dupont - INSERM, France
Manel Esteller - Bellvitge Institute for Biomedical Research, Barcelona, ES
Francesca Finotello - University of Innsbruck, Austria
Jose Manuel Fuentes - Universidad de Extremadura, Cáceres, ES
Dmitry I. Gabrilovich - The Wistar Institute, Philadelphia, PA, US
Abhishek Garg - KU Leuven, Belgium
Robyn Gartrell - Columbia University, USA
Francois Ghiringhelli - Centre Georges Francois Leclerc, France
Ana Patricia Da Silva Gomes - Moffitt Cancer Center, USA
Eyal Gottlieb - The Beatson Institute for Cancer Research, Glasgow, UK
Douglas R. Green - Memphis, TN, US
Congcong He - Northwestern University, USA
Jules A. Hoffmann - Institut de Biologie Moléculaire et Cellulaire, Strasbourg, FR
Richard A. Knight - University College London, London, UK
Guillermina Lozano - MD Anderson Cancer Center, University of Texas, Houston, TX, US
Alberto Mantovani - Humanitas Research Hospital, University of Milan, Rozzano, IT
Saverio Marchi - Marche Polytechnic University, Italy
Noboru Mizushima - The University of Tokyo, Tokyo, JP
Ute Moll - Stony Brook, NY, US
David Montrose - Stony Brook Medical Center, USA
Andrea Morandi - University of Florence, Italy
Gabriel Nunez - University of Michigan Medical School, Ann Arbor, MI, US
Moshe Oren - Weizmann Institute of Science, Rehovot, IL
Marcus E. Peter - Feinberg School of Medicine, Northwestern University, Chicago, IL, US
Federico Pietrocola - Karolinska Institute, Sweden
Paolo Ettore Porporato - University of Torino, Italy
Thomas Postler - Columbia University, USA
George Prendergast - The Lankenau Institute for Medical Research, Wynnewood, PA, US
Kodi Ravichandran - University of Virginia School of Medicine, Charlottesville, VA, US
Nicholas Restifo - Center for Cancer Research, National Cancer Institute - Chevy Chase, MD, US
Chiara Riganti - University of Torino, Italy
Nils-Petter Rudqvist - MD Anderson Cancer Center, University of Texas, USA
Maria Esperanza Rodriguez-Ruiz - Clinica Universidad de Navarra, Spain
Gregg L. Semenza - Johns Hopkins University School of Medicine, Baltimore, MD, US
Wen Shen - Weill Cornell Medical College, NY, USA
Mark Smyth - Herston, QLD, AU
Robbert Spaapen - Sanquin Research, University of Amsterdam, Netherlands
Clement Thomas - Luxembourg Institute of Health, Luxembourg
Sharon A. Tooze - London Research Institute, London, UK
Matthew G. Vander Heiden - Koch Institute, Massachusetts Institute of Technology, Cambridge, MA, US
Claire Vanpouille-Box - Weill Cornell Medical College, NY, USA
Peter K. Vogt - La Jolla, CA, US
Karen H. Vousden - Beatson Institute for Cancer Research, Glasgow, UK

Abstracting and indexing

Molecular & Cellular Oncology is abstracted/indexed in:
  • DOAJ
  • National Library of Medicine
    - PubMed Central (PMC)
  • Scopus

Open access

Molecular & Cellular Oncology is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.

Why choose open access?

  1. Increase the discoverability and readership of your article
  2. Make an impact and reach new readers, not just those with easy access to a research library
  3. Freely share your work with anyone, anywhere
  4. Comply with funding mandates and meet the requirements of your institution, employer or funder
  5. Rigorous peer review for every open access article

Article Publishing Charges (APC)

To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.

Use our APC finder to calculate your article publishing charge

Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .

Ready to submit?

Start a new submission or continue a submission in progress

Go to submission site (link opens in a new window) Instructions for authors